 |
ActRIIB-IgG1) |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-16 00:00:00 |
| Sponsor | Acceleron Pharma, Inc.;128 Sidney St.;Cambridge, Massachusetts, 02139 |
| |
ActRIIB-IgG1) |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-16 00:00:00 |
| Sponsor | Acceleron Pharma, Inc.;128 Sidney St.;Cambridge, Massachusetts, 02139 |